Statpedia’s Post

3D Printing Medical Devices Market Projected to Expand by $4.2 Billion by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/e8ybNh7Y The global size of 3D printing medical devices market in terms of revenue was estimated to be worth USD 2.7 billion in 2022 and is poised to reach USD 6.9 billion by 2028, growing at a CAGR of 17.1% from 2022 to 2028 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Stratasys 3D Systems Corporation Materialise GE Additive Renishaw Desktop Metal PRODWAYS GROUP Nikon SLM Solutions CELLINK Organovo Holdings, Inc. EOS Formlabs Carbon 3T Additive Manufacturing Ltd Biomedical Modeling Inc. Dentsply Sirona Roland DG Corporation DWS Hydrotherapy Systems Ltd REGENHU Protolabs Triastek, Inc. FABRX Aprecia Pharmaceuticals Fluicell GeSiM Gesellschaft fuer Silizium-Mikrosysteme mbH Inventia Life Science

3D Printing Medical Devices Market Projected to Expand by $4.2 Billion by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞:https://lnkd.in/d_4wQMm2 The global size of 3D printing medical devices market in terms of revenue was estimated to be worth USD 2.7 billion in 2022 and is poised to reach USD 6.9 billion by 2028, growing at a CAGR of 17.1% from 2022 to 2028 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Stratasys 3D Systems Corporation Materialise GE Additive Renishaw Desktop Metal PRODWAYS GROUP Nikon SLM Solutions CELLINK Organovo Holdings, Inc. EOS Formlabs Carbon 3T Additive Manufacturing Ltd Biomedical Modeling Inc. Dentsply Sirona Roland DG Corporation DWS Hydrotherapy Systems Ltd REGENHU Protolabs Triastek, Inc. FABRX Aprecia Pharmaceuticals Fluicell GeSiM Gesellschaft fuer Silizium-Mikrosysteme mbH Inventia Life Science

3D Printing Medical Devices Market Anticipated to reach $6.9 Billion by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:https://lnkd.in/dbxgQHA5 The global size of 3D printing medical devices market in terms of revenue was estimated to be worth USD 2.7 billion in 2022 and is poised to reach USD 6.9 billion by 2028, growing at a CAGR of 17.1% from 2022 to 2028. 𝐌𝐚𝐢𝐧 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Stratasys 3D Systems Corporation Materialise GE Additive Renishaw Desktop Metal PRODWAYS GROUP SLM Solutions Group AG CELLINK Organovo Holdings, Inc. EOS Formlabs Carbon 3T Additive Manufacturing Ltd Biomedical Modeling Inc. Dentsply Sirona Roland DG EMEA DWS - Digital Wax Systems REGENHU HP Protolabs Triastek, Inc. FABRX Aprecia Pharmaceuticals Fluicell GeSiM Gesellschaft fuer Silizium-Mikrosysteme mbH Inventia Healthcare Limited

3D Printing Medical Devices Market Anticipated to reach $6.9 Billion by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:https://lnkd.in/dbxgQHA5 The global size of 3D printing medical devices market in terms of revenue was estimated to be worth USD 2.7 billion in 2022 and is poised to reach USD 6.9 billion by 2028, growing at a CAGR of 17.1% from 2022 to 2028. 𝐌𝐚𝐢𝐧 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Stratasys 3D Systems Corporation Materialise GE Additive Renishaw Desktop Metal PRODWAYS GROUP SLM Solutions Group AG CELLINK Organovo Holdings, Inc. EOS Formlabs Carbon 3T Additive Manufacturing Ltd Biomedical Modeling Inc. Dentsply Sirona Roland DG EMEA DWS - Digital Wax Systems REGENHU HP Protolabs Triastek, Inc. FABRX Aprecia Pharmaceuticals Fluicell GeSiM Gesellschaft fuer Silizium-Mikrosysteme mbH Inventia Healthcare Limited

The global size of 𝟑𝐃 𝐩𝐫𝐢𝐧𝐭𝐢𝐧𝐠 𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 market in terms of revenue was estimated to be worth USD 2.7 billion in 2022 and is poised to reach USD 6.9 billion by 2028, growing at a CAGR of 17.1% from 2022 to 2028. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐚𝐭 https://lnkd.in/dK7pXVjr North America region of the 3d printing medical devices market is expected to be the largest market during the forecast period. 𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Stratasys Stratasys Medical Deutschland 3D Systems Corporation Materialise Materialise Motion GE Additive Renishaw Renishaw India Desktop Metal PRODWAYS GROUP Nikon SLM Solutions GROUP CELLINK Organovo Holdings, Inc. EOS Formlabs Formlabs Singapore Carbon 3T Additive Manufacturing Ltd Biomedical Modeling Inc. Dentsply Sirona Roland DG Corporation Roland DGA DWS - Digital Wax Systems REGENHU HP FiT Protolabs Triastek, Inc. FABRX Aprecia Pharmaceuticals Fluicell GeSiM Gesellschaft fuer Silizium-Mikrosysteme mbH Inventia Life Science

3D Printing Medical Devices Market | Grows at CAGR of 17.1% by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞-https://lnkd.in/dbxgQHA5 3D printing medical devices market in terms of revenue was estimated to be worth $2.7 billion in 2022 and is poised to reach $6.9 billion by 2028, growing at a CAGR of 17.1% from 2022 to 2028. Stratasys 3D Systems Corporation Materialise GE Additive Renishaw Desktop Metal PRODWAYS GROUP SLM Solutions Group AG CELLINK Organovo Holdings, Inc. EOS Formlabs 3T Additive Manufacturing Ltd Biomedical Modeling Inc. Dentsply Sirona Roland DG EMEA DWS Hydrotherapy Systems Ltd REGENHU HP Protolabs Triastek, Inc. FABRX Aprecia Pharmaceuticals Fluicell GeSiM Gesellschaft fuer Silizium-Mikrosysteme mbH Inventia Healthcare Limited

3D Printing Medical Devices Market Worth $6.9 billion by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬: https://lnkd.in/ddD2ycV3 The global size of 3D printing medical devices market in terms of revenue was estimated to be worth USD 2.7 billion in 2022 and is poised to reach USD 6.9 billion by 2028, growing at a CAGR of 17.1% from 2022 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Stratasys 3D Systems Corporation. Materialise GE Additive Renishaw Desktop Metal PRODWAYS GROUP SLM Solutions Group AG CELLINK Organovo Holdings, Inc. EOS Formlabs Carbon 3T Additive Manufacturing Ltd Biomedical Modeling Inc. Dentsply Sirona Roland DG Corporation REGENHU HP Protolabs Triastek, Inc. FABRX Aprecia Pharmaceuticals Fluicell GeSiM Gesellschaft fuer Silizium-Mikrosysteme mbH Inventia Healthcare Limited

🔬 Transforming Healthcare with Medical 3D Printing 🔬 3D printing is revolutionizing healthcare, enabling personalized care with applications ranging from custom implants and surgical guides to patient-specific devices. With technologies like FDM, SLA, SLS, and HP’s Multi Jet Fusion (MJF), medical professionals can select the right method and biocompatible materials to match each application. Key polymers, such as Nylon 12 PA used in MJF, offer safe, customizable, and sterilizable options ideal for prosthetics and implants. According to The Insight Partners, the medical 3D printing market is expected to reach $10.65 billion by 2031, growing at a 17.5% annual rate. This expansion underscores the potential of 3D printing to provide faster production, customization, and broader material options in healthcare. #3DPrinting #HealthcareInnovation #AdditiveManufacturing #MedicalDevices #PersonalizedCare #BiocompatibleMaterials

The 3D Printing Medical Devices Market is on the rise and it's HUGE! 🌟 By 2029, it's projected to skyrocket to $4.5 billion 💵, with an incredible #CAGR of 14.7% from 2024 to 2029! 📈 #3Dprinting has significantly influenced the development of customized #medicaldevices. This #market is experiencing significant growth driven by advancements in #technology, increasing demand for personalized medical solutions and the rising adoption of innovative #manufacturing methods in the #healthcare sector. From #personalizedimplants to revolutionary prosthetics, 3D printing is transforming #medicaltech and patient care. 🌍💉 Stay tuned and follow us for more updates on this exciting journey in medical advancements! 🔍 https://bit.ly/3Ly5Gi2 #HealthcareInnovation #MarketTrends #MarketResearch #FutureOfMedicine #MarketGrowth #MarketResearch #InvestInTech #MedicalTech #BCCResearch #HealthcareTech #Bioprinting #DigitalHealth #PersonalizedMedicine

3D Printing Medical Devices Market | Grows at CAGR of 17.1% by 2028 ☑️𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/d-zFr4rX The global size of 3D printing medical devices market in terms of revenue was estimated to be worth USD 2.7 billion in 2022 and is poised to reach USD 6.9 billion by 2028, growing at a CAGR of 17.1% from 2022 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Stratasys 3D Systems Corporation Materialise GE Additive Renishaw Desktop Metal PRODWAYS GROUP SLM Solutions Group AG CELLINK Organovo Holdings, Inc. EOS Formlabs Carbon 3T Additive Manufacturing Ltd Biomedical Modeling Inc. Dentsply Sirona Roland DGA REGENHU HP Protolabs Triastek, Inc. FABRX Aprecia Pharmaceuticals Fluicell Inventia Healthcare Limited